Andriolo, S., Rouanet, J-M., Lafont, J. and Besancon, P., 1984, Inactivation of phaseolamin, an alpha-amylase inhibitor from Phaseolus vulgaris, by gastric acid and digestive proteases. Nutr. Rep. Int., 29, 149 - 156.

Arner, P., 1993, Adenosine, prostaglandins and phosphodiesterase as targets for obesity pharmacotherapy. Int. J. Obesity, 17, S57 - S60.

Astrup, A., 1986, Thermogenesis in human brown adipose tissue and skeletal muscle induced by sympathicomimetic stimulation. Acta Endocrinol. Suppl., 278, 1 - 32.

Astrup, A., Lundsgaard, C., Madsen, J. and Christensen, N.J., 1985, Enhanced thermogenic responsiveness during chronic ephedrine treatment in man. Am. J. Clin. Nutr., 42, 83 - 94.

Astrup, A., Madsen, J., Holst, J.J. and Christensen, N.J., 1986, The effect of chronic ephedrine treatment on substrate utilization, the sympathoadrenal activity, and energy expenditure during glucose-induced thermogenesis in man. Metabolism, 35, 260 - 265.

Astrup, A., Toubro, S., Cannon, S., Hein, P. and Madsen, J., 1990a, Thermogenic, metabolic and cardiovascular effects of a sympathomimetic agent, ephedrine. Curr. Ther. Res., 48, 1087 - 1100.

Astrup, A., Toubro, S., Cannon, S., Hein, P. Breum, L. and Madsen, J., 1990b, Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic and cardiovascular effects in healthy volunteers. Am. J. Clin. Nutr., 51, 759 - 767.

Astrup, A., Breum, L., Toubro, S., Hein, P. and Quaade, F., 1992a, The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int. J. Obesity, 16, 169 - 277.

Astrup, A., Buemann, B., Christensen, N.J., Toubro, S., Thorbek, G., Victor, O.J. and Quaade, F., 1992b, The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women. Metabolism, 41, 686 - 688.

Astrup, A., Breum, L., Toubro, S., Hein, P. and Quaade, F., 1992c, Ephedrine and weight loss. Int. J. Obesity, 16, 715.

Astrup, A., Toubro, S., Christensen, N.J. and Quaade, F., 1992d, Pharmacology of thermogenic drugs. Am. J. Clin. Nutr., 55, 246S - 248S.

Astrup, A. and Toubro, S., 1993, Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man. Int. J. Obesity, 17, S41 - S44.

Astrup, A. and Toubro, S., 1993, Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man. Int. J. Obesity, 17, S41 - S44.

Attela, M.J., Hoffman, S.W., Stasio, M.J. and Stein, D.G., 1989, Ginkgo biloba extract facilitates recovery from penetrating brain injury in adult male rats. Exp. Neurol., 105, 62 - 71.

Bal Dit Sollier, C., Caplain, H. and Drouet, L., 2003, No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clin. Lab. Haematol., 25, 251 - 253.

Barth, S.A., Inselmann, G., Engemann, R. and Heidemann, H.T., 1991, Influences of Ginkgo biloba on cyclosporin A induced lipid peroxidation in human liver microsomes in comparison to vitamin E, glutathione and N-acetylcysteine. Biochem. Pharmacol., 41, 1521 - 1526.

Bennett, D.A. Jr., Polk J.F., Voglino, S.A., Zlotnik, V. and Raffa, R.B., 1998. Neuropharmacology of St. John's wort (Hypericum). Ann. Pharmacother., 32, 1201 - 1208.

Le Berre-Anton, V., Bompard-Gilles, C., Payan, F. and Rouge, P., 1997, Characterization and functional properties of the alpha-amylase inhibitor (alpha-AI) from kidney bean (Phaseolus vulgaris) seeds. Biochim. Biophys. Acta., 1343, 31 - 40.

BIAM (Banque de Données Automatisée sur les Médicaments): http://www.biam2.org

Blumenthal, M., Busse, W.R., Goldberg, A., Gruenwald, J., Hall, T., Riggins. C.W. and Rister, R., 1998, The Complete German Commission E Monographs: Therapeutic guide to herbal medicines.
Newton, MA: Integrative Medicine Communications.

Bo-Linn, G.W., Santa Ana, C.A., Morawski, S.G. and Fordtran, J.S., 1982, Starch blockers - their effect on calorie absorption from a high-starch meal. N. Engl. J. Med., 307, 1413 - 1416.

Bown, D., 1995, The Encyclopedia of Herbs & Their Uses. Dorling Kindersly, London.

Braquet, P., Laurent, J.P., Rolland, A., Martin, C., Pommier, J., Hosford, D. and Eaanu, A., 1990, From ginkgolides to N-substituted piperidonothiene diazepines, a new series of highly potent dual antagonists. Adv. Prostaglandin, Thromboxane, Leucotriene Res., 21B, 929 - 937.

Breum, L., Pedersen, J.K., Ahlstrom, F. and Frimodt-Moller, J., 1994, Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-center trial in general practice. Int. J. Obesity, 18, 99 - 103.

British Herbal Pharmacopoeia, 1983, 115 - 116. British Herbal Medicine Association, Bournemouth.

Bruel, A., Gardette, J., Berrou, E., Droy-Lefaix, M.T. and Picard, J., 1989, Effects of Ginkgo biloba extract on glucose transport and glycogen synthesis of cultured smooth muscle cells from pig aorta. Pharmacol. Res., 21, 421 - 429.

Bukowiecki, L.J., Lupien, J., Folléa, N. and Jahjah, L., 1983, Effects of sucrose, caffeine, and cola beverages on obesity, cold resistance and adipose tissue cellularity. Am. J. Physiol., 244, R500 - R507.

Buemann, B., Marckmann, P., Christensen, N.J. and Astrup, A., 1994, The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet. Int. J. Obesity, 18, 329 - 332.

Buslig, B. and Manthey, J.A., 2005, Furanocoumarins in grapefruit juice fractions. Session 104, IFT Annual Meeting, July 15-20 - New Orleans, Louisiana

Carlson, G.L., Li, B.U., Bass, P. and Olsen, W.A., 1983, A bean alpha-amylase inhibitor formulation (starch blocker) is ineffective in man. Science, 219, 393 - 395.

Carpene, C., Galitzky, J., Fontana, E., Atgie, C., Lafontan, M. and Berlan, M., 1999, Selective activation of beta-3-adrenoceptors by octopamine; comparative studies in mammalian fat cells. Naunyn Schmiedebergs Arch. Pharmacol., 359, 310 - 321.

Chen, K.K., 1925, A pharmacognostic and chemical study of Ma huang (Ephedra vulgaris var. Helvetica). J. Am. Pharm. Assoc., 14, 189 - 194.

Chen, C., Jin, R.M., Li, Y., Sheng, Y., Zhou, M., Chen, S. and Zhou, Z., 1991, [Improvement of memory in mice by extracts from leaves of Ginkgo biloba L.]. Chung Kuo Chung Yao Tsa Chih (CHINA), 16, 681 - 683.

Chen, X., Liu, L.Y., Deng, H.W., Fang, Y.X. and Ye, Y.W. 1981, [The effects of Citrus aurantium and its active ingredient N-methyltyramine on the cardiovascular receptors]. Yao Hsueh Hsueh Pao (CHINA), 16, 253 - 259.

Cheng, J.T. and Tsai, J.T., 1991, Octopamine: an endogenous blocker of dopamine D-1 receptors. Adv. Exp. Med. Biol., 287, 237 - 240.

Cheung, W.T., Lee, C.M. and Ng, T,B., 1988, Potentiation of the antilipolytic effect of 2-chloroadenosine after chronic caffeine treatment. Pharmacology, 36, 331 - 339.

Colker, C.M., Kalman, D.S., Torina, G.C., Perlis, T. and Street, C., 1999, Effects of Citrus aurantium extract, caffeine, and St. John's Wort on body fat loss, lipid levels, and mood states in overweight healthy adults. Curr. Ther. Res., 60, 145 - 153.

Collins, L.C., Cornelius, M.F., Vogel, R.I., Walker, J.F. and Stamford, B.A., 1994, Effect of caffeine and/or cigarette smoking on resting energy expenditure. Int. J. Obesity, 18, 551 - 556.

Compendium Suisse des Medicaments: http://www.kompendium.ch

Cooper, R., Morre, D.J. and Morre, D.M., 2005a, Medicinal benefits of green tea: Part I. Review of noncancer health benefits. J. Altern. Complement. Med., 11, 521 - 528.

Cooper, R., Morre, D.J. and Morre, D.M., 2005b, Medicinal benefits of green tea: part II. review of anticancer properties. J. Altern. Complement. Med., 11, 639 -652.

Court, J.M., Dunlop, M.E. and Boulton, T.J., 1974, Effect of ephedrine in ketotic hypoglycaemia. Arch. Dis. Child., 49, 63 - 65.

Daly, P., Krieger, D., Dulloo, A., Young, J. and Landsberg, L., 1993, Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity. Int. J. Obesity, 17, S73 - S78.

Ding, X.F., 1986, [Strains and quality of zhiqiao in Jiangxi Province]. Chung Yao Tung Pao (CHINA), 11, 11 - 12.

Douds, D.A., 1997, Acute oral toxicity study in rats with Zhi shi extract a/k/a/ . Springborn Laboratories, Study No. SLI 3443.1.

Drug Facts and Comparisons, 1995, Facts and Comparisons, St. Louis.

Dukes, J.A., 1985. Handbook of Medicinal Herbs. CRC Press, Boca Raton.

Dulloo, A.G. and Miller, D.S., 1986, The thermogenic properties of ephedrine/methylxanthine mixtures: human studies. Int. J. Obes., 10, 467 - 481.

Dulloo, A.G. and Miller, D.S., 1987, Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity. Am. J. Clin. Nutr., 45, 564 - 569.

Dulloo, A.G. and Miller, D.S., 1989, Ephedrine, caffeine and aspirin: "over-the-counter" drugs that interact to stimulate thermogenesis in the obese. Nutrition, 5, 7 - 9.

Dulloo, A.G., Seydoux, J. and Girardier, L., 1991, Peripheral mechanisms of thermogenesis induced by ephedrine and caffeine in brown adipose tissue. Int. J. Obes., 15, 317 - 326.

Dulloo, A.G., 1993, Ephedrine, xanthines and prostaglandin inhibitors: actions and interactions in the stimulation of thermogenesis. Int. J. Obesity, 17, S35 - S40.

Eckmann, F., 1990, Hirnleistungsstörungen - - Behandlung mit Ginkgo-biloba-Extrakt. Zeitpunkt der Wirkungseintritte in einer Doppelblindstudie mit 60 stationären Patienten. Fortschr. Med., 108, 557 - 560.

Engelsen, J., Nielsen, J.D., and Hansen, K.F., 2003, [Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr. Laeger., 165, 1868 – 1871.

Evans, P.D. and Robb, S., 1993, Octopamine receptor subtypes and their modes of action. Neurochem. Res., 18, 869 - 874.

Evans, P.D., Robb, S., Cheek, T.R., Reale, V., Hannan. F.L., Swales, L.S., Hall, L.M., and Midgley, J.M., 1995, Agonist-specific coupling of G-protein-coupled receptors to second-messenger systems. Prog. Brain Res., 106, 259 - 268.

Fang, X.D., 1985, [The chemical constituents of Citrus reticulata]. Chung Yao Tung Pao (CHINA), 10, 77 - 78.

FAO, 1995, Fats and oils in human nutrition, Report of a joint expert consultation (1993), FAO Food and Nutrition Papers, No. 57.

Font Quer, P., (1982), "Plantes Medicinales; el Dioscorides renovado". Editorial Labor S.A., Madrid.

Fontana, E., Morin, N., Prevot, D. and Carpene, C., 2000, Effects of octopamine on lipolysis, glucose transport and amine oxidation in mammalian fat cells. Comp. Biochem. Physiol. C., 125, 33 - 44.

Fugh-Berman, A., and Cott, J., 1999, Dietary supplements and natural products as psychotherapeutic agents. Psychosomatic Medicine, 61, 712 - 728.

Fünfgeld, E.W., 1989, A natural and broad spectrum noötropic substance for treatment of SDAT - - the Ginkgo biloba extract. Prog. Clin. Biol. Res., 317, 1247 - 1260.

Gahart, B.L., 1985, Intravenous medications; a Handbook for Nurses and other allied health professionals. 4th Edition, The C.V. Mosby Company, 200 - 201.

Galitzky, J., Carpene, C., Lafontan, M. and Berlan, M., 1993, Stimulation spécifique des récepteurs β3-adrénergiques du tissu adipeux par l’octopamine, C.R. Acad. Sci. Paris, Sciences de la Vie, 316, 519 – 523

Garrow, J.S., Scott, P.F., Heels, S., Nair, K.S. and Halliday, D., 1983, A study of 'starch blockers' in man using 13C-enriched starch as a tracer. Hum. Nutr. Clin. Nutr., 37, 301 - 305.

Geissler, C., 1993, Effects of weight loss, ephedrine and aspirin on energy expenditure in obese women. Int. J. Obesity, 17, S45 - S48.

Gerard, J., 1597, The Herball or Generall Historie of Plantes, John Norton, London. Second Edition enlarged and amended by Thomas Johnson, 1633, and reprinted 1636 [Note: translation of Dodoens' Stirpium Historiae Pemptades Sex, Antwerp, 1583].

Goodman, L. and Gilman, G., 1941, The Pharmacological Basis of Therapeutics. Macmillan, New York (First Edition).

Goubern, M., Yazbeck, J., Senault, C. and Portet, R., 1990, Non-shivering thermogenesis and brown adipose tissue activity in essential fatty acid deficient rats. Arch. Int. Physiol. Biochim.,
98, 193 - 199.

Gougeon, R., Miriam, A., Lamarche, M. and Morais, J.A., 2001, Extracts of alkaloids from Citrus aurantium potentiate the thermic response of a meal in obese subjects. Diabetes, 50, A533.

Gougeon, R., Tremblay, J.-F., Hedrei, P., Pathak, B., Adam, M., Harrigan, K., Lamarche, M. and Morais, J.A., 2003, A lower thermic effect of food (TEF) in women vs. men is increased with a synephrine-containing extract from Citrus aurantium. 18th International Diabetes Federation Congress, August, 2003, Paris.

Gougeon, R., Harrigan, K., Tremblay, J.F., Hedrei, P., Lamarche, M. and Morais, J.A., 2005, Increase in the thermic effect of food in women by adrenergic amines extracted from citrus aurantium. Obes. Res., 13, 1187 – 1194.

Govoni, L.E. and Hayes, J.E., 1985, Drugs and Nursing Implications. Appleton-Century-Crofts, Norwalk.

Granum, P.E., Holm, H., Wilcox, E. and Whitaker, J.R., 1983, Inhibitory properties of 2 commercially available starch blocker preparations. Nutr. Rep. Int., 28, 1233 - 1244.

Grassel, E., 1992, Einfluss von Ginkgo-biloba-Extrakt auf die geistige Leistungsfähigkeit. Doppelblindstudie unter computerisierten Messbedingungen bei Patienten mit Zerebralinsuffizienz. Fortschr. Med., 110, 73 - 76.

Grieve, M., 1992, A Modern Herbal. Dorset Press, New York.

Gunn, T.R., Ball, K.T. and Gluckman, P.D., 1993, Withdrawal of placental prostaglandins permits thermogenic responses in fetal sheep brown adipose tissue. J. Appl. Physiol., 74, 998-1004.

Hedrei, P and Gougeon, R., 1997, Thermogenic effect of beta-sympathicomimetic compounds extracted from Citrus aurantium. McGill Nutrition and Food Science Center, Royal Victoria Hospital.

Hindmarch, I., 1988, Activity of Ginkgo biloba extract on short-term memory. In "Rökan (Ginkgo biloba), Recent results in Pharmacology and Clinic". Fünfgeld (Ed.), Berlin, Springer Verlag, 321 - 326.

van het Hof, K.H., Wiseman, S.A., Yang, C.S., and Tijburg, L.B., 1999, Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Proc. Soc. Exp. Biol. Med., 1999, 220, 203 - 209.

Hofferberth, B., 1989, Einfluss von Ginkgo-biloba-Extrakt auf neurophysiologische und psychometrische Messergebnisse bei Patienten mit hirnorganischem Psychosyndrom. Ein Doppelblindstudie gegen Plazebo. Arzneimittelforschung, 39, 918 - 922.

Hollenbeck, C.B., Coulston, A.M., Quan, R., Becker, T.R., Vreman, H.J., Stevenson, D.K. and Reaven, G.M., 1983, Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption in vivo and in vitro studies. Am. J. Clin. Nutr., 38, 498 - 503.

Hopkins, D.F., Cotton, S.J. and Williams, G., 1993, Effective treatment of insulin-induced edema using ephedrine. Diabetes Care, 16, 1026 - 1028.

Houglum, J.E. and Chappell, G.S., 1984, Quantitative determination of the alpha-amylase inhibitor from Phaseolus vulgaris using size exclusion high-performance liquid chromatography. J. Liq. Chromatograph., 7, 2895 - 2904.


Hosoda, K., Noguchi, M., Kanaya, T. and Higuchi, M, 1990, [Studies on the preparation and evaluation of Kijitsu, the immature citrus fruits. III. Relation between diameter of Kijitsu and synephrine content]. Yakugaku Zasshi (JAPAN), 110, 82 - 84.

Hosoda, K., Noguchi, M., Chen, Y.P. and Hsu, H.Y., 1991, [Studies on the preparation and evaluation of Kijitsu, the immature citrus fruits. IV. Biological activities of immature fruits of different citrus species], Yakugaku Zasshi (JAPAN), 111, 188 - 192.

Huang, K.C., 1993, The Pharmacology of Chinese Herbs, 21 - 45, 173. CRC Press, Boca Raton.

Huang, W.T.. Wang, G.F., Chen, C.F., Chen, C.C., Hong, C.Y. and Yang, M.C. (1995), Fructus aurantii reduced portal pressure in portal hypertensive rats. Life Sci., 57, 2011 - 2020.

Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O. and McLachlan, A.J,, 2005, Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br. J. Clin. Pharmacol., 2005, 59, 425 - 432

Jonderko, K. and Kucio, C., 1991, Effect of anti-obesity drugs promoting energy expenditure, yohimbine and ephedrine, on gastric emptying in obese patients. Aliment. Pharmacol. Ther., 5, 413 - 418.

Jones, P.J.H. and Schoeller, D.A., 1988, Polyunsaturated:saturated ratio of diet fat influences energy substrate utilization in the human. Metabolism, 37, 145 - 151.

Jones, D. and Egger, T.E., 1993, Use of herbs containing natural source ephedrine alkaloids in weight loss programmes. Int. J. Obes., 17, S81.

Jones, D., 1998, Citrus aurantium. All Natural Muscular Development, 2.98, 108 - 110, 176.

Jones, D., 2001, Regulation of appetite, body weight and athletic function with materials derived from citrus varieties. U.S. Patent 6,224,873.

Jones, D., 2001, Methods for increasing the muscle mass of a human with materials derived from citrus varieties. U.S. Patent 6,316,499.

Jones, D., 2002, Regulation of athletic function with materials derived from citrus varieties. U.S. Patent 6,340,481.

Jones, D., 2002, Methods for inducing weight loss in a human with materials derived from Citrus varieties. U.S. Patent 6,340,482.

Jones, D., 2004, The regulation of appetite, body weight and athletic function with materials derived from Citrus varieties. Canadian Patent 2,248.854.

Jones, D., 2004a, Citrus and Ephedra, Whole Foods, April, 40 – 42.

Jung, F., Mrowietz, C., Kiesewetter, H. and Wenzel, E., 1990, Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Arzneimittelforschung, 40, 589 - 593.

Kaats, G.R. and Adelman, J.A., 1994, Effects of a multiple herbal formulation on body composition, blood chemistry, vital signs, and self-reported energy levels & appetite control. Int. J. Obesity, 18 (Supp. 2), S145. Also personal communication.

Kaats, G.R., Michalek, J.E. and Preuss, H.G., 2006, Evaluating efficacy of a chitosan product using a double-blinded, placebo-controlled protocol. J.Am.Coll.Nutr., 25, 389 – 394.

Kalman, D.S., 1999, Natural Fat Loss Pill; Citrus aurantium, caffeine and St. John's Wort. Muscular Development, 6.99, 122 - 125.

Kim, H.L., Streltzer, J. and Goebert, D., 1999, St. John's Wort for depression: A meta-analysis of well-defined clinical trials. J. Nervous Mental Dis., 187, 532 - 539.

Koltringer, P., Eber, O., Klima, G., Rothlauer, W., Wakonig, P., Langsteger, W. and Lind, P., 1989, Die Mikrozirkulation unter parenteraler Ginkgo-biloba-Extrakt-Therapie. Wien. Klin. Wochenschr., 101, 198 - 200.

Kowalchik, C., and Hylton, W., 1987, Rodale's Illustrated Encyclopaedia of Herbs. Rodale Press, Emmaus, Pennsylvania.

Krieger, D.R., Daly, P.A., Dulloo, A.G., Ransil, B.J., Young, J.B. and Landsberg, L., 1990, Ephedrine, caffeine and aspirin promote weight loss in obese subjects. Trans. Assoc. Am. Physicians, 103, 307 - 312.

Kuriyama, S., Shimazu, T., Ohmori, K., Kikuchi, N., Nakaya, N., Nishino, Y., Tsubono, Y. and Tsuji, I., 2006, Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. J. Am. Med. Assoc., 296, 1255 - 1265.

Landsberg, L. and Young, Y.B., 1993, Sympathoadrenal activity and obesity: physiological rationale for the use of adrenergic thermogenic drugs. Int. J. Obesity, 17, S29 - S34.

Langley-Evans, S.C., 2000, Antioxidant potential of green and black tea determined using the ferric reducing power (FRAP) assay. Int. J. Food Sci. Nutr., 2000, 51, 181 - 188.

Layer, P., Anderson, C.A., Zinsmeister, A.R. and DiMagno, E.P., 1984, Partially purified amylase inhibitor is a starch blocker, it decreases starch digestion and postprandial plasma glucose in humans. Gastroenterol., 86, 1155.

Layer, P., Rizza, R.A., Go, V.L.W. and DiMagno, E.P., 1985, A starch blocker purified amylase inhibitor that improves postprandial carbohydrate tolerance in patients with with non-insulin dependent diabetes mellitus. Gastroenterol., 88, 1468.

Layer, P., Rizza, R.A., Zinsmeister, A.R., Carlson, G.L. and DiMagno, E.P., 1986, Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus. Mayo Clin. Proc., 61, 442 - 447.

Leenen, R., Roodenburg, A.J., Tijburg, L.B., and Wiseman, S.A., 2000, A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur. J. Clin. Nutr., 54, 87 - 92.

Lewis, W.H. and Elvin-Lewis, M.P.F., 1977, Medical Botany. John Wiley & Sons, New York.

Li Shih-Chen, 1596, Ben Cao Kong Mu, Peking, China.

Liu, C.X. and Xiao, P.G., 1992, Recent advances on ginseng research in China. J. Ethnopharmacol., 36, 27 - 38.

Lowe, F.C. and Jarow, J.P., 1993, Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology, 42, 51 - 54.

Malchow-Moller, A., Larsen, S., Hey, H., Stokholm, K.H., Juhl, E. and Quaade, F., 1980, Effekten af Helsingor-pillen i behandlingen af adipositas. En kontrolleret klinisk undersogelse. Ugeskr. Laeger., 142, 1496 - 1499.

Malchow-Moller, A., Larsen, S., Hey, H., Stokholm, K.H., Juhl, E. and Quaade, F., 1981, Ephedrine as an anorectic: the story of the 'Elsinore pill'. Int. J. Obes., 5, 183 - 187.

Markowitz, J.S., Donovan, J.L., DeVane, C.L.., Taylor, R.M., Ruan, Y., Wang, J.-S. and Chavin, K.D., 2003, Effect of St John's Wort on Drug Metabolism by Induction of Cytochrome P450 3A4 Enzyme.
J.A.M. A., 290, 1500 – 1504.

Matthews, W.B., 1983, The autonomic nervous system, in Oxford Textbook of Medicine, Ed. Weatherall, D.J., Ledingham, J.G.G. and Warrell, D.A., 21.23, Oxford University Press, Oxford, New York, Toronto.

McGuffin, M., Hobbs, C., Upton, R. and Goldberg, A., 1997, American Herbal Product Association’s Botanical Safety Handbook: Guidelines for the Safe Use and Labeling for Herbs of Commerce. Boca Raton, FL: CRC Press.

Mhurchu, C.N., Poppitt, S.D., McGill, A.T., Leahy, F.E., Bennett, D.A., Lin, R.B., Ormrod, D., Ward, L., Strik, C. and Rodgers, A., 2004, The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults. Int. J. Obes. Relat. Metab. Disord., 28, 1149 - 1156.

Molnar, D., 1993, Effects of ephedrine and aminophylline on resting energy expenditure in obese adolescents. Int. J. Obesity, 17, S49 - S52.

Moritz, O, 1953, Einfnhrung in die allgemeine Pharmakognosie. 2nd Edition, Jena, 305 - 306.

Müller, W.E., Singer, A., Wonnemann, M., Rolli, M., Schafer, C. and Hafner, U., 1998, Wirkungen von standardisierten Johanniskraut- Extrakt (LI 160) in biochemischen Modellen antidepressiver Wirksamkeit. Psychopharmakother. Suppl., 5, 40 - 45.

Munson, P.L. (Ed.), 1995, Principles of Pharmacology; basic concepts and clinical applications. Chapman & Hall, New York.

Nahoum, V., Roux, G., Anton, V., Rouge, P., Puigserver, A., Bischoff, H., Henrissat, B. and Payan, F., 2000, Crystal structures of human pancreatic alpha-amylase in complex with carbohydrate and proteinaceous inhibitors. Biochem. J., 346, 201 - 208.

Ng, T.B. and Yeung, H.W., 1985, Hypoglycemic constituents of Panax ginseng. Gen. Pharmacol., 16, 549 - 552.

Nielsen, B., Astrup, A., Samuelsen, P., Wengholt, H. and Christensen, N.J., 1993, Effect of physical training on thermogenic responses to cold and ephedrine in obesity. Int. J. Obesity, 17, 383 - 390.

Otamiri, T. and Tagesson, C., 1989, Ginkgo biloba extract prevents mucosal damage associated with small-intestinal ischaemia. Scand. J. Gastroenterol., 24, 666 - 670.

Ou Ming, 1989, Chinese-English Manual of Common-Used in Traditional Chinese Medicine; Guangdong Science & Technology Publishing House and Joint Publishing (H.K.) Co., Ltd., Hong Kong.

Pasquali, R., Baraldi, G., Cesari, M.P., Melchionda, N., Zamboni, M., Stefanini, C. and Raitano, A., 1985, A controlled trial using ephedrine in the treatment of obesity. Int. J. Obes., 9, 93 - 98.

Pasquali. R., Cesari, M.P., Melchionda, N., Stefanini, C., Raitano, A. and Labo, G., 1987a, Does ephedrine promote weight loss in low-energy-adapted obese women? Int. J. Obes., 11, 163 - 168.

Pasquali. R., Cesari, M.P., Bestighi, L., Melchionda, N. and Balestra, V., 1987b, Thermogenic agents in the treatment of human obesity: preliminary results. Int. J. Obes., 11, Suppl. 3, 23 - 26.

Pasquali, R., Casimirri, F., Melchionda, N., Grossi, G., Bortoluzzi, L., Morselli Labate, A.M., Stefanini, C. and Raitano, A., 1992, Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects. Clin. Sci., 82, 85 - 92.

Pasquali, R. and Casimirri, F., 1993, Clinical aspects of ephedrine in the treatment of obesity. Int. J. Obesity, 17, S65 - S68.

Pathak, B. and Gougeon, R., 1998, Thermic effect of Citrus aurantium in obese subjects. McGill Nutrition and Food Science Center, Royal Victoria Hospital.

Perovic, S. and Müller, W.E., 1995, Pharmacological profile of Hypericum extract. Effect on serotonin uptake by postsynaptic receptors. Arzneimittelforschung, 45, 1145 - 1148.

Pincemail, J., Dupuis, M., Nasr, C., Hans, P., Haag-Berrurier, M., Anton, R. and Deby, C., 1989, Superoxide anion scavenging effect and superoxide dismutase activity of Ginkgo biloba extract. Experientia, 45, 708 - 712.

Quaade, F., Astrup, A., Breum, L., Toubro, S. and Hein, P., 1992, Effekten af en efedrin/koffein-kombination som understottelse af en affedningsdiaet. En randomiseret, placebokontrolleret, dobbeltblind undersogelse. Ugeskr. Laeger., 154, 1258 - 1263.

Raabe, A., Raabe, M. and Ihm, P., 1991, Therapieverlaufskontrolle mittels automatisierter Perimetrie bei chronischer zerebroretinaler Mangelsversorgung älterer Patienten. Prospektive randomisierte Doppelblinduntersuchung mit dosisgestaffelter Ginkgo biloba Behandlung (EGb 761). Klin. Monatsbl. Augenheilkd., 199, 432.

Rai, G.S., Shovlin, C. and Wesnes, K.A., 1991, A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment. Curr. Med. Res. Opin., 12, 350 - 355.

Reid, D.P., 1986, Chinese Herbal Medicine. Shambhala, Boston.

Reynolds, J.E.F., Ed., 1982, Martindale; the Extra Pharmacopoeia, 28th Edition. The Pharmaceutical Press, London.

Robinson, E.E., Maxwell, S.R. and Thorpe, G.H., 1997, An investigation of the antioxidant activity of black tea using enhanced chemiluminescence. Free Radic. Res., 26, 291 - 302.

Roed, P., Hansen, P.W., Bidstrup, B., Kaern, M., Helles, A. and Petersen, K.P., 1980, Helsingor-slankepiller. En kontrolleret klinisk undersogelse i almenpraksis. Ugeskr. Laeger., 142, 1491 - 1495.

Rosenfeld, M., Catalano, M., Quashie, A., Sklar, N. and Brugge, W., 1984, Inhibition of amylase activity by starch blocker results in carbohydrate malabsorption. Gastroenterol., 86, 1223.

Santimone, M., Koukiekolo, R., Moreau, Y., Le Berre, V., Rouge, P., Marchis-Mouren, G. and Desseaux, V., 2004, Porcine pancreatic alpha-amylase inhibition by the kidney bean (Phaseolus vulgaris) inhibitor (alpha-AI1) and structural changes in the alpha-amylase inhibitor complex. Biochim. Biophys. Acta, 1696, 181 - 190.

Shulgin, A.T., 1966, Possible implication of myristicin as a psychotropic substance. Nature, 210, 380 - 384.

Snead, T.J. and Jackson C.W., 1999, St. John's wort: A review of an herbal antidepressant. J. Pharm. Pract., 12, 210 - 216.

Southon, I.W. and Buckingham, J., (Eds.), 1989, Dictionary of Alkaloids, 1st Edition, Main Work (Chapman & Hall). See also Dictionary of Organic Compounds, 1982, 5th Edition, Main Work (Chapman & Hall).

Stokholm, K.H. and Hansen, M.S., 1983, Lowering of serum total T3 during a conventional slimming regime. Int. J. Obes., 7, 195 - 199.

Streeten, D.H., 1975, The role of posture in idiopathic oedema. S. Afr. Med. J., 49, 462 - 464.

Stuart, M., 1979, The Encyclopaedia of Herbs and Herbalism. Orbis Publishing Limited, London.

Tagliabue, A., Terracina, D., Cena, H., Turconi, G., Lanzola, E. and Montomoli, C., 1994, Coffee induced thermogenesis and skin temperature. Int. J. Obesity, 18, 537 - 541.

Takada, R., Saitoh, M. and Mori, T., 1994, Dietary gamma-linolenic acid-enriched oil reduces body fat content and induces liver enzyme activities relating to fatty acid beta-oxidation in rats. J.Nutr., 124, 469 - 474.

Tormo, M.A., Gil-Exojo, I., Romero de Tejada, A. and Campillo, J.E., 2004, Hypoglycaemic and anorexigenic activities of an alpha-amylase inhibitor from white kidney beans (Phaseolus vulgaris) in Wistar rats. Br. J. Nutr., 92, 785 - 790.

Toubro, S., Astrup, A., Breum, L. and Quaade, F., 1993, Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture. Int. J. Obesity, 17, S69 - S72.

Truitt, E.B., Callaway, E., Braude, M.C. and Krantz, J.C., 1961, The pharmacology of myristicin; a contribution to the psychopharmacology of nutmeg. J. Neuropsychiat., 2, 205 - 210.

Truitt, E.B., Duritz, G. and Ebersberger, E.M., 1963, Evidence of monoamine oxidase inhibition by myristicin and nutmeg. Proc. Soc. Exp. Biol. and Med., 112, 647 - 650.

Truitt, E.B., 1967, The pharmacology of myristicin and nutmeg. Psychopharmacol. Bull., 4, 14.

Tyler, V.E., 1982, The Honest Herbal - A sensible guide to the use of herbs and related remedies. George F. Stickley, Philadelphia.

Umoren, J. and Kies, C., 1992, Commercial soybean starch blocker consumption impact on weight gain and on copper, lead and zinc status of rats. Plant Foods Hum. Nutr., 42, 135 - 142.

Vallerand, A., 1993, Effects of ephedrine/xanthines on thermogenesis and cold tolerance. Int. J. Obesity, 17, S53 - S56.

Wenke, M., Lincova, D., Cernohorsky, M. and Cepelik, J., 1967, Some aspects concerning the structure-function relationship in lipomobilizing adrenomimetics. Arch. int. Pharmacodyn., 165, 53 - 63.

Wheaton, T.A. and Stewart, I., 1970, The distribution of tyramine, N-methyltyramine, hordenine, octopamine and synephrine in higher plants. Lloydia, 33, 244 - 254.

Wichtl, M., Ed., 1994, Herbal Drugs and Phytopharmaceuticals, Trans. Bissett, N.G., CRC Press, Boca Raton.

Williams, C.M., Couch, M.W., Thonoor, C.M. and Midgley, J.M., 1987, Isomeric octopamines: their occurrence and functions. J. Pharm. Pharmacol., 39, 153 - 157.

Winter, E., 1991, Effects of an extract of Ginkgo biloba on learning and memory in mice. Pharmacol. Biochem. Behav., 38, 109 - 114.

Wolfram, S., Wang, Y. and Thielecke, F., 2006, Anti-obesity effects of green tea: from bedside to bench. Mol. Nutr. Food Res., 50, 176 – 187.

Yang, Y.T. and McElligott, M.A., 1989, Multiple actions of β-adrenergic agonists on skeletal muscle and adipose tissue. Biochem. J., 261, 1 - 10.

Yen, S.T., Li, M.H., Hsu, C.T., Lee, T.L. and Cheng, J.T., 1998, Stimulatory effect of octopamine on β3-adrenoceptors to lower the uptake of [14C]-deoxy-D-glucose into rat adipocytes in vitro. J. Autonomic Pharmacol., 18, 13 – 19.

Ylitalo, R., Lehtinen, S., Wuolijoki, E., Ylitalo, P. and Lehtimaki, T., 2002, Cholesterol-lowering properties and safety of chitosan. Arzneimittelforschung, 52, 1 - 7.

Yoshida, T., Sakane, N., Umekawa, T. and Kondo, M., 1994, Relationship between basal metabolic rate, thermogenic response to caffeine, and body weight loss following combined low calorie and exercise treatment in obese women. Int. J. Obesity, 18, 345 - 350.

Zaveri, N.T., 2006, Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci., 78, 2073 - 2080.

Zhang, H., Xu, L., Jin, Q., Zhou, L. and Cheng, P., 1990, [Anti-anaphylactic pharmacological action of water-soluble constituents of Ginkgo biloba L. episperm]. Chung Kuo Chung Yao Tsa Chih (CHINA), 15, 496 - 497.

Zhang, Z.Z., Fan, C.S. and Huang, A.H., 1989, [A study on the quality of fruits of Citrus aurantium L. (Zhishi and Zhiqiao) produced in Jiangxi]. Chung Kuo Chung Yao Tsa Chih (CHINA), 14, 520 - 522, 573.